Recon

4 Early Observations about the combined Zimmer-Biomet

Please Read the Entire Article at OrthoStreams

 

#1 – The big picture numbers of the deal 

Both boards have approved the definitive merger agreement. Closing is expected in 1Q 2015. Total price is $13.35B. Zimmer will pay $10.35B in cash and $3B in Z stock (represents about 17% of outstanding shares).  At closing, Zimmer’s shareholders will own 84% of the merged company and Biomet’s shareholders will own 16%.  Zimmer will take on all of Biomet’s debt.  Zimmer’s market cap is about $17B ($100 per share X 169M shares). Biomet is obviously worth $13B, so this is as much a merger as an acquisition.

 

 

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button